Market

Income Statement

You can view the Income Statement for the last 5 years.

INCOME STATEMENT

Suven Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 16437.26 P/BV 9.47 Book Value ( ₹ ) 68.16
52 Week High/Low ( ₹ ) 768/469 FV/ML 1/1 P/E(X) 39.97
Book Closure 15/12/2023 EPS ( ₹ ) 16.16 Div Yield (%) 0.00
(₹ in Crs.)

ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
Months121212125
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.001.001.001.001.00
      
      
INCOME     
Revenue From Operations [Net]1331.111307.01995.46817.28369.57
Other Operating Revenues9.2213.2114.2516.518.26
Total Operating Revenues1340.331320.221009.72833.79377.83
      
Other Income46.3692.3814.2418.120.60
Total Revenue1386.691412.601023.96851.91378.43
      
EXPENSES     
Cost Of Materials Consumed430.08459.46310.32240.24124.52
Operating And Direct Expenses176.29173.19122.73105.7551.30
Changes In Inventories Of FG,WIP And Stock-In Trade-20.94-60.35-8.37-11.05-21.32
Employee Benefit Expenses110.51100.4887.2973.7229.63
Finance Costs5.446.239.1423.072.79
Depreciation And Amortisation Expenses47.7339.1031.6423.8611.50
Other Expenses77.8668.0257.2740.0222.15
Total Expenses826.96786.12610.02495.61220.57
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax559.73626.48413.94356.30157.87
      
Profit/Loss Before Tax559.73626.48413.94356.30157.87
      
Tax Expenses-Continued Operations     
Current Tax146.27190.40101.5488.8133.17
Deferred Tax4.3423.383.62-1.3015.42
Tax For Earlier Years-2.170.000.180.000.00
Total Tax Expenses148.44213.79105.3387.5148.59
Profit/Loss After Tax And Before ExtraOrdinary Items411.29412.69308.61268.79109.27
      
Profit/Loss From Continuing Operations411.29412.69308.61268.79109.27
      
Profit/Loss For The Period411.29412.69308.61268.79109.27
Share Of Profit/Loss Of Associates0.0041.1153.7448.210.00
Consolidated Profit/Loss After MI And Associates411.29453.80362.34317.00109.27
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)16.1617.8314.2324.918.59
Diluted EPS (Rs.)16.1617.8314.2324.918.59
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend203.65101.8325.4663.6419.09
Tax On Dividend0.000.000.0013.083.92
ParticularsMar 23
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue1.00
  
INCOME 
Revenue From Operations [Net]1331.11
Other Operating Revenues9.22
Total Operating Revenues1340.33
Other Income46.36
Total Revenue1386.69
EXPENSES 
Cost Of Materials Consumed430.08
Operating And Direct Expenses176.29
Changes In Inventories Of FG,WIP And Stock-In Trade-20.94
Employee Benefit Expenses110.51
Finance Costs5.44
Depreciation And Amortisation Expenses47.73
Other Expenses77.86
Total Expenses826.96
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax559.73
Profit/Loss Before Tax559.73
Tax Expenses-Continued Operations 
Current Tax146.27
Deferred Tax4.34
Tax For Earlier Years-2.17
Total Tax Expenses148.44
Profit/Loss After Tax And Before ExtraOrdinary Items411.29
Profit/Loss From Continuing Operations411.29
Profit/Loss For The Period411.29
Share Of Profit/Loss Of Associates0.00
Consolidated Profit/Loss After MI And Associates411.29
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)16.16
Diluted EPS (Rs.)16.16
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend203.65
Tax On Dividend0.00